<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03074461</url>
  </required_header>
  <id_info>
    <org_study_id>17-129</org_study_id>
    <nct_id>NCT03074461</nct_id>
  </id_info>
  <brief_title>Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial</brief_title>
  <acronym>CSAR</acronym>
  <official_title>Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CSAR Trial's aim is to determine whether the transverse coloplasty pouch or the side-to-end
      anastomosis as rectal reservoir reconstruction offers the best functional results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study directly compares two neorectal reservoir-techniques, the transverse coloplasty
      and the side-to-end anastomosis, in low anterior resection in distal rectal cancer for the
      first time. Its focus is on the functional results. Besides stool frequency, the quality of
      life, safety of the procedures and the usage of stool modulating drugs is monitored in an 12
      months-follow up regime.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2017</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study participants will be randomized in two parallel study arms regarding their neorectal reconstruction in low anterior resection, the experimental arm using the side-to-end anastomosis and the control group using the transverse coloplasty technique.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>There is no masking in the CSAR Trial</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Stool frequency</measure>
    <time_frame>time = 6 months postoperative</time_frame>
    <description>Between group differences in stool frequency at t = 6 months postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>through study completion (an average of 12 months postoperative)</time_frame>
    <description>Septic intraabdominal complications related to anastomosis (anastomotic insufficiencies, suture insufficiencies, abscesses);
Wound infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>baseline, postoperative (2-3 months, 6 months, 12 months)</time_frame>
    <description>Quality of Life with focus on colorectally specialized questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antimotility drug usage</measure>
    <time_frame>baseline, postoperative (2-3 months, 6 months, 12 months)</time_frame>
    <description>Usage of antimotility drugs (e.g. loperamide) evaluated by standardized questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Rectal Neoplasms</condition>
  <condition>Rectal Tumors</condition>
  <condition>Fecal Incontinence</condition>
  <arm_group>
    <arm_group_label>Side-to-End</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side-to-End Anastomosis as neorectal reconstruction technique in low anterior resection (LAR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transverse Coloplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transverse Coloplasty pouch as neorectal reconstruction technique in low anterior resection (LAR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Side-to-End Anastomosis</intervention_name>
    <description>During the scheduled low anterior resection (LAR) in patients with distal rectal cancer and anticipated anastomosis in the mid or distal rectal third, the reconstruction phase of the LAR consists of the implementation of a side-to-end colorectal anastomosis.</description>
    <arm_group_label>Side-to-End</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transverse Coloplasty</intervention_name>
    <description>During the scheduled low anterior resection (LAR) in patients with distal rectal cancer and anticipated anastomosis in the mid or distal rectal third, the reconstruction phase of the LAR consists of the implementation of a transverse coloplasty pouch. For this purpose an end-to-end colorectal anastomosis is initially performed, followed by a longitudinal incision of approx. 8-10 cm length proximal of the anastomosis and a subsequent transverse suture in terms of the coloplasty technique.</description>
    <arm_group_label>Transverse Coloplasty</arm_group_label>
    <other_name>Coloplasty Pouch, Transverse Coloplasty Pouch</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled low anterior resection in patients with distal rectal carcinoma and planned
             anastomosis in mid/distal third of rectum

          -  Local curative approach

          -  Normal continence preoperatively

          -  Non-IBD-associated carcinoma

          -  Possible sphincter salvage

          -  Signed informed consent

        Exclusion Criteria:

          -  Non-curative approaches

          -  Emergency surgery in cases of tumor perforation, abscess, sepsis

          -  Proximal rectal carcinoma (&gt; 12 cm from anocutaneous line)

          -  Lack of informed consent

          -  Age &lt;18 years

          -  Inclusion in other trials with interference of endpoints

          -  Life expectancy less than 24 months (as estimated by the treating physicians)

          -  Pregnancy

          -  Immunosuppression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Rentsch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of General, Visceral, and Transplantation Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Markus Rentsch, MD</last_name>
    <phone>0049/89/4400/711213</phone>
    <email>markus.rentsch@med.uni-muenchen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandro M Hasenhütl, MD</last_name>
    <phone>0049/89/4400/711242</phone>
    <email>sandro.hasenhuetl@med.uni-muenchen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maria-Theresia-Klinik</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas Hölscher, MD</last_name>
      <phone>0049/89/7207325</phone>
      <email>dr.hoelscher@maria-theresia-klinik.de</email>
    </contact>
    <contact_backup>
      <last_name>Carolin Orlitsch, MD</last_name>
      <phone>0049/89/7207325</phone>
      <email>dr.orlitsch@maria-theresia-klinik.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Barmherzige Brüder München</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80639</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johann Spatz, MD</last_name>
      <phone>0049/89/17972302</phone>
      <email>johann.spatz@barmherzige-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Rentsch, MD</last_name>
      <phone>0049/89/4400/711213</phone>
      <email>markus.rentsch@med.uni-muenchen.de</email>
    </contact>
    <contact_backup>
      <last_name>Sandro M Hasenhütl, MD</last_name>
      <phone>0049/89/4400/711242</phone>
      <email>sandro.hasenhuetl@med.uni-muenchen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2017</study_first_submitted>
  <study_first_submitted_qc>March 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>May 31, 2017</last_update_submitted>
  <last_update_submitted_qc>May 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Markus Rentsch</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Rectal Cancer</keyword>
  <keyword>Low Anterior Resection</keyword>
  <keyword>Coloplasty Pouch</keyword>
  <keyword>Side-to-end Anastomosis</keyword>
  <keyword>Continence</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Fecal Incontinence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to third parties beyond the study team.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

